Results 81 to 90 of about 860,145 (127)

Disproportionality analysis of post-marketing safety concerns associated with selumetinib in the FDA adverse event reporting system. [PDF]

Sci Rep
Liu F, Su H, Wei W.
europepmc   +1 more source

Pharmacovigilance for Vaccines Used in Pregnancy: A Gap Analysis From Uganda. [PDF]

Pediatr Infect Dis J
Nambasa VP, Ssebagereka A, Ssali A, Namugumya R, Nalubega P, Figueras A, Kajungu D, Koch B, Le Doare K, Kampmann B.   +9 more
europepmc   +1 more source

Knowledge, Attitude, Practice, and Barriers of Adverse Drug Reaction Reporting Among Healthcare Professionals in Timor-Leste: A Cross-Sectional Survey. [PDF]

Clin Transl Sci
da Costa J, Nosoongnoen W, Rungapiromnan W, Tragulpiankit P.   +3 more
europepmc   +1 more source

Comparative Analysis of Neuropsychiatric Adverse Reactions Associated with Remdesivir and Nirmatrelvir/Ritonavir in COVID-19 Treatment: Insights from EudraVigilance Data. [PDF]

J Clin Med
Pacnejer AM, Negru MC, Arseniu AM, Trandafirescu C, Oancea C, Gligor FG, Morgovan C, Butuca A, Dehelean CA.   +8 more
europepmc   +1 more source

Incidence of Adverse Drug Reactions Among HIV Patients on Antiretroviral Drugs in Ethiopia: A Systematic Review and Meta-Analysis. [PDF]

AIDS Res Treat
Endalamew SG, Assefa SK, Getachew MS, Arage FG, Asgedom DK, Terefe B, Teshome DF.   +6 more
europepmc   +1 more source

Reply: [Post-marketing safety concerns with Lecanemab: a disproportionality analysis using the FDA adverse event reporting system]. [PDF]

Alzheimers Res Ther
Xing X, Wang K, Dong X.
europepmc   +1 more source

Adverse events associated with hepatic arterial infusion chemotherapy and its combination therapies in hepatocellular carcinoma: a systematic review. [PDF]

Front Immunol
Wu Y, Zeng Z, Chen S, Zhou D, Tong G, Du D.   +5 more
europepmc   +1 more source

Risk comparison of adverse reactions between gemcitabine monotherapy and gemcitabine combined with albumin-bound paclitaxel in pancreatic cancer: insights from the FDA Adverse Event Reporting System (FAERS) database. [PDF]

BMC Pharmacol Toxicol
Jiang P, Zong K, Peng D, Zhou B, Wu Z.
europepmc   +1 more source

Exploring the influencing factors of adverse drug reaction reporting among medical personnel: a COM-B model-based study. [PDF]

J Pharm Policy Pract
Cheng W, Du J, Chen C, Cao J, Xia X, Yang X, Zhang W, Jia X, Qi Y.   +8 more
europepmc   +1 more source

Post-marketing safety surveillance of vortioxetine hydrobromide: a pharmacovigilance study leveraging FAERS database. [PDF]

Front Psychiatry
Zhang Y, Sun S, Ning Y.
europepmc   +1 more source